Emerald Advisers, LLC Abbott Laboratories Transaction History

Emerald Advisers, LLC

$2.35 Billion
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $194,617 - $214,945	-1,777 Reduced 22.67%	6,060 $688,000
Q4 2023 Feb 05, 2024	BUY	$90.19 - $110.4 $21,555 - $26,385	239 Added 3.15%	7,837 $862,000
Q4 2022 Feb 03, 2023	SELL	$95.06 - $111.52 $16,540 - $19,404	-174 Reduced 2.24%	7,598 $834,000
Q3 2022 Oct 25, 2022	BUY	$96.76 - $112.03 $110,306 - $127,714	1,140 Added 17.19%	7,772 $752,000
Q2 2022 Jul 29, 2022	BUY	$102.07 - $123.37 $305,903 - $369,739	2,997 Added 82.45%	6,632 $721,000
Q1 2022 Apr 29, 2022	BUY	$114.02 - $139.04 $353,462 - $431,024	3,100 Added 579.44%	3,635 $430,000
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $61,808 - $75,681	535 New	535 $75,000
Q3 2021 Oct 28, 2021	SELL	$116.66 - $129.06 $62,413 - $69,047	-535 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $56,597 - $66,623	535 New	535 $62,000
Q1 2021 Apr 29, 2021	SELL	$108.84 - $128.23 $58,229 - $68,603	-535 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $220,210 - $267,429	-2,403 Reduced 81.79%	535 $58,000
Q2 2020 Jul 28, 2020	SELL	$76.57 - $98.0 $9,647 - $12,348	-126 Reduced 4.11%	2,938 $269,000
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $402,487 - $588,547	-6,407 Reduced 67.65%	3,064 $242,000
Q4 2019 Jan 29, 2020	SELL	$78.51 - $87.4 $4,632 - $5,156	-59 Reduced 0.62%	9,471 $823,000
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $90,678 - $98,323	-1,108 Reduced 10.42%	9,530 $797,000
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $214,996 - $250,750	-2,950 Reduced 21.71%	10,638 $895,000
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $3,244 - $3,922	-49 Reduced 0.36%	13,588 $1.09 Million
Q4 2018 Jan 30, 2019	SELL	$65.56 - $74.27 $112,107 - $127,001	-1,710 Reduced 11.14%	13,637 $986,000
Q3 2018 Oct 31, 2018	SELL	$60.81 - $73.36 $23,229 - $28,023	-382 Reduced 2.43%	15,347 $1.13 Million
Q2 2018 Jul 31, 2018	SELL	$57.57 - $63.54 $47,783 - $52,738	-830 Reduced 5.01%	15,729 $959,000
Q1 2018 Apr 26, 2018	SELL	$56.27 - $63.62 $65,779 - $74,371	-1,169 Reduced 6.59%	16,559 $992,000
Q4 2017 Feb 05, 2018	SELL	$53.68 - $57.47 $43,534 - $46,608	-811 Reduced 4.37%	17,728 $1.01 Million
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $890,984 - $994,431	18,539	18,539 $989,000

Others Institutions Holding ABT

# of Institutions

3,275

Shares Held

1.31B

Call Options Held

9.63M

Put Options Held

8.36M

Vanguard Group Inc Valley Forge, PA

169M
Shares

$22.2 Billion
0.34% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$17.2 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$10.1 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$8.64 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$7.01 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $230B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account